Kaposi’s sarcoma-associated herpesvirus (KSHV) / human herpesvirus-8 is the causative
agent of the endothelial cell-derived tumour Kaposi’s sarcoma. Herpesviruses possess
large complex genomes which provide many options to regulate cellular physiology during
the viral life cycle and in the course of tumourigenicity. Novel techniques of systems
biology and reverse genetics are increasingly applied to dissect the complex interaction
of KSHV with endothelial cells. This review will outline novel results and pitfalls
of these technologies in the elucidation of KSHV pathogenicity.
Keywords
Endothelial cells - angiogenesis - apoptosis - NF-kappaB - interferon